Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
Brings extensive experience in all phases of oncology drug developmentHANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals,...
Stay updated with breaking news from Processa Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brings extensive experience in all phases of oncology drug developmentHANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals,...
/PRNewswire/ -- DelveInsight's Gastroparesis Market Insights report includes a comprehensive understanding of current treatment practices, gastroparesis...
Insiders who bought US$210.6k worth of Processa Pharmaceuticals, Inc. ( NASDAQ:PCSA ) stock in the last year recovered...
HANOVER, MD, Feb. 14, 2024 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...